
Statistical Analysis Plan (SAP) - TLF Part

Table of Contents

1 List of Tables and Charts for Results Section of the iCSR
The following selection of tables and figures is given for information for the ghost report writing. The final choice/decision at the time of the iCSR writing will depend on various issues: clinical team review of the ghost report, results, standard presentation chosen by the company.

2 Section?9 of the iCSR (Tables and Charts)


List of Tables
	

List of Figures 

Table 2.1: Subject Enrollment by Investigator and Randomized Group ¨C Cohort 1
N: this is a footnote for N
[1] this is a footnote for something
[2] this is a footnote for something
[3] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
[4] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
	

Table 2.2: Subject Enrollment by Investigator and Randomized Group - Cohort 2
N: this is a footnote for N
[1] this is a footnote for something
[2] this is a footnote for something
[3] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
[4] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
<Same method as previous>
Table 2.3: Subject Enrollment by Investigator and Randomized Group - Cohort 3
N: this is a footnote for N
[1] this is a footnote for something
[2] this is a footnote for something
[3] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
[4] this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote this is a footnote for something
<Same method as previous>


Figure 2.1: Bar Chart of Change in Diastolic & Systolic Blood Pressure at Final Visit

[1] this is a footnote for something
[2] this is a footnote for something

Figure 2.2: Kaplan-Meire Survival Curve
[1] this is a footnote for something
[2] this is a footnote for something
 

3 Appendix?16 of the iCSR (Individual Patient/Data Listings)


List of Listings
Listing 3.1: Demographics and Baseline Characteristics	10


Listing 3.1: Demographics and Baseline Characteristics

SAS Global Forum 2012                                                      
Orlando, Florida


SAS Global Forum 2012                                                      
Orlando, Florida
                                                                                                


SAS Global Forum 2012                                                      
Orlando, Florida



SAS Global Forum 2012                                                      
Orlando, Florida


sanofi pasteur                                                                                                                                                                                          FINAL SAP TLF GRC43 
Quadrivalent Influenza Vaccine                                                                                                   

